[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604793":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":29,"locations":35,"responsibleParty":51,"collaborators":10,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":10,"studyType":68,"phases":10,"briefSummary":69,"conditions":70,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Tanta University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Group I",null,"Neonates with gestational ages between 28 and 34 gestational weeks.",[13,14],"Diagnostic Test: Serum endocan","Diagnostic Test: Serum copeptin",{"label":16,"type":10,"description":17,"interventionNames":18},"Group II","Neonates with gestational ages between 34 and 36 gestational weeks.",[13,14],[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","Serum endocan","Serum endocan will be measured by an enzyme-linked immunosorbent assay (ELISA) on the first day of life.",[9,16],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"Serum copeptin","Serum copeptin will be measured by an enzyme-linked immunosorbent assay (ELISA) on the first day of life.",[9,16],[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Asmaa M Elmesiry, MD","CONTACT","00201224285567","asmaa.elmesery@med.tanta.edu.eg",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Tanta","El-Gharbia","31527","Egypt","EG",{"type":44,"coordinates":45},"Point",[46,47],31.00192,30.78847,{"lat":47,"lon":46},[50],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Asmaa Mahmoud Abdel Hamid Elmesiry","Lecturer of Pediatrics, Faculty of Medicine, Tanta University, Tanta, Egypt.","100604793","endocan-and-copeptin-serum-levels-in-preterm-neonates-with-respiratory-distress-syndrome-100604793",false,"NCT07154134","Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome","Comparative Study Between Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome","Inclusion Criteria:\n\n* Prematurity.\n* Gestational age between 28 and 36 weeks.\n* Suffering from respiratory distress syndrome.\n\nExclusion Criteria:\n\n* Intrauterine growth restriction (IUGR).\n* Hypoxic ischemic encephalopathy.\n* Multiple congenital anomalies.\n* Chromosomal abnormalities.\n* Preterm less than 28 weeks.\n* Neonates with a maternal history of chorioamnionitis (early sepsis).\n* Infant of diabetic mother.\n* Prelabor rupture of membranes (PROM)\\> 2 hours.","ALL","28 Weeks","36 Weeks",{"count":66,"type":67},40,"ESTIMATED","OBSERVATIONAL","This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.",[71,72,73,74,75],"Endocan","Copeptin","Serum","Preterm Neonates","Respiratory Distress Syndrome","2025-08-27",{"date":78,"type":79},"2025-09-04","ACTUAL",{"date":81,"type":79},"2025-07-10",{"date":83,"type":67},"2025-11-01",{"name":5,"class":6},1]